PolyPid Akcija

PolyPid EBITDA

Vrijednost EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od PolyPid (PYPD) na dan 16. авг 2026. je -32,97 М USD. Prethodne godine, EBITDA (Заработак пре камата, пореза, амортизације и отписивања) je bio -28,03 М USD — promjena od 17,62% (niži).

EBITDA

-32,97 МUSD

YoY

17,62%

Zadnja ažuriranja:

EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od PolyPid je 2026 -32,97 М USD. EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od PolyPid je bio 2025 -28,03 М USD. Pad je time 17,62% niži u odnosu na prethodnu godinu.
Access this data via the Eulerpool API

PolyPid Анализа акција

Šta radi PolyPid? PolyPid Ltd is an innovative, emerging company in the field of biomedical technology based in Israel. The company was founded in 2008 and has since gained continuous recognition and growth. PolyPid's core business is the development and manufacturing of implantable polymer systems that contribute to wound healing. These polymer systems are specifically introduced into the affected area of the body and continuously release active substances to prevent infections and promote natural healing processes. PolyPid's business model is focused on effectively solving patients' problems. The company has developed a wide range of products and technologies that specifically target various medical applications. These include orthopedics, traumatology, urology, and gynecology. For orthopedics, PolyPid provides various products and technologies that can be used in knee and hip joint surgeries. These include antibiotic-releasing implants to prevent infections and resorbable bone fillers that allow for faster and more effective wound healing. In the field of traumatology, PolyPid manufactures polymer systems that are used in the treatment of bone fractures or other traumas. Here again, the polymer systems ensure continuous release of active substances to prevent infections and promote natural healing processes. PolyPid also offers innovative solutions for urology. Specifically, products are developed to combat urinary tract infections and promote faster wound healing after urological surgeries. For gynecology, PolyPid offers polymer systems that can be used particularly in the postoperative phase to prevent infections and achieve faster wound healing. PolyPid has earned an excellent reputation in the industry in recent years due to its consistent focus on innovation and quality. To continually improve their products, the company invests heavily in research and development and maintains close contact with medical institutions and professionals worldwide. PolyPid is an important partner in the field of biomedical technology and has already received numerous awards for its groundbreaking products and developments. Thanks to its focus on quality, reliability, and innovation, the company will continue to play a key role in the biomedical technology market. PolyPid je jedna od najpopularnijih kompanija na Eulerpool.

Često postavljena pitanja o akciji PolyPid

EBITDA (Заработак пре камата, пореза, амортизације и отписивања) kompanije PolyPid iznosi -32,97 М USD u 2026. godini.

EBITDA (Заработак пре камата, пореза, амортизације и отписивања) od PolyPid se promijenio sa -28,03 М USD na -32,97 М USD, što predstavlja promjenu od 17,62%. Vrijednost je niži nego prethodne godine.

Na Eulerpool-u možete pronaći potpuni historijski razvoj EBITDA (Заработак пре камата, пореза, амортизације и отписивања) PolyPid od 2006. — sa godišnjim vrijednostima, grafikonima i detaljnom analizom.

EBITDA мери оперативну перформансу пре утицаја финансијске структуре, окружења пореза и не-готовинских отписивања.

EBITDA = EBIT + Амортизација и отписивање

EBITDA (Заработак пре камата, пореза, амортизације и отписивања)'s USD je ključan faktor za investitore. Promene u ovoj metrici mogu signalizirati poboljšane ili pogoršane fundamentalne faktore, direktno utiču na cenu akcije. Na Eulopoolu, možete pratiti EBITDA (Заработак пре камата, пореза, амортизације и отписивања)'s PolyPid istorijski i u realnom vremenu.

Access this data via the Eulerpool API

Извештај о добити и губитку — PolyPid

Sve ključne metrike — PolyPid

Раст